The European Commission has approved Bavarian Nordic's (OTCPK:BVNRY)(OTCPK:BVNKF) mpox shot for adolescents between 12 and 17 ...
"This study reinforces the benefit in vaccinating against mpox with MVA-BN and reaffirms that a single dose provides at least ...
The World Health Organization Friday approved MVA-BN as the first mpox vaccine added to its pre-qualification list.
The WHO said Friday it had for the first time prequalified an mpox vaccine -- a move expected to speed up access to the jabs to fight an epidemic raging in Africa.
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMARepresents the second EMA approval of an MVA-BN-based vaccine for a younger ...